Ellegaard Göttingen Minipigs

What Ellegaard Göttingen Minipigs does

Ellegaard Göttingen Minipigs A/S is a privately-held Danish company that develops, breeds, and supplies the proprietary Göttingen Minipig strain as a preclinical animal model for biomedical research. The breed was first established in 1969 at Georg-August-University in Göttingen, Germany, and Ellegaard operates as the global sole breeder and developer. The company is headquartered in Dalmose, Denmark, and runs a North American subsidiary, Ellegaard Bioresearch, serving customers across the United States and Canada. It supplies pharmaceutical companies, biotechnology firms, contract research organizations (CROs), and academic institutions worldwide with minipigs used in toxicology, safety assessment, and drug development studies.

The product portfolio centers on the Göttingen Minipig itself — a barrier-bred research animal available across age, weight, and gender specifications — and extends to genetically altered variants, biological material for in vitro studies, contract research services, and a structured educational offering. The Humanized IgG1/IgG4 Göttingen Minipig, commercialized in October 2022 following a Nature publication, is a proprietary genetically altered model carrying a mini-repertoire of human immunoglobulin heavy chain γ1/γ4 and κ light chain genes; it tolerates human antibodies and is positioned as an alternative to non-human primates in therapeutic antibody toxicology testing. An additional smaller variant, the Göttingen Micropig, is under development. The company maintains an extensive proprietary background data library covering histopathology, clinical chemistry, growth curves, and MR/CT imaging atlases — the latter developed in collaboration with Aarhus University's CENSE center — which underpins regulatory acceptance and study design.

Ellegaard generates revenue primarily through direct sales of animals and biological material on a per-transaction basis, supplemented by contract research services (in vivo and PK studies) and tiered Academy course fees ranging from free introductory webinars to €1,300 for advanced hands-on training. The go-to-market is direct enterprise field sales, with regional managers covering North America (John Cameron), continental Europe (Olivier Dillenseger), and international accounts (Peter Vestbjerg), supported by a dedicated logistics function for global animal shipments. Scientific engagement is anchored by attendance at 30+ major toxicology and biomedical conferences annually (SOT, EUROTOX, ACT, SPS, AFSTAL, FELASA, GV-SOLAS) and by company-organized Göttingen Minipigs Symposiums in major US cities. Named customers include top-tier pharma (Novo Nordisk, Roche, AstraZeneca, Sanofi, Novartis, Janssen) and leading CROs (Labcorp, Scantox, Covance).

Name

Ellegaard Göttingen Minipigs

Legal name

Ellegaard Göttingen Minipigs A/S

Website

https://minipigs.dk

Company type

Private

Founded year

1992

Operating status

Operating

Headcount range

11–50 employees

Short description

Ellegaard Göttingen Minipigs A/S breeds and globally supplies the proprietary Göttingen Minipig strain for preclinical biomedical research. The Danish firm serves pharmaceutical companies, biotech firms, CROs, and academic institutions with barrier-bred animals, genetically altered models, research services, and training.

Ownership category

akta.pro rank

Headquarters

HQ city

Dalmose

HQ country

Denmark

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Supply Chain, Infrastructure, Marketing or Sales, Technology or R&D

Revenue model

1. Göttingen Minipig Sales: Supply of Göttingen Minipigs of all ages, weight groups, and both genders for biomedical research. Animals are barrier-bred and supplied globally to pharmaceutical companies, biotech firms, and research institutions.
2. Genetically Altered Minipigs: Supply of genetically modified Göttingen Minipigs including Humanized IgG1/IgG4 models for specialized toxicology and safety testing applications.
3. Biological Material: Sale of biological material from Göttingen Minipigs for in vitro research applications including skin for transdermal studies and vascular tissue for ex vivo studies.
4. Research Services: Contract research services including in vivo studies, PK studies, and study design assistance. Services range from project kick-off to delivery.
5. Göttingen Minipigs Academy: Educational courses and training programs on Göttingen Minipigs including veterinary management, handling and dosing, anaesthesia & analgesia, vascular access, and animal welfare. Both in-person and online courses available.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels10 records

Core offering

Ellegaard Göttingen Minipigs develops, breeds, and globally supplies Göttingen Minipigs as non-rodent preclinical animal models for pharmaceutical, biotechnology, and academic biomedical research. The portfolio includes standard barrier-bred minipigs, genetically altered lines (including Humanized IgG1/IgG4 models for therapeutic antibody testing), biological materials for in vitro studies, contract research services (in vivo studies, PK studies, study design), and an educational Academy offering training in handling, dosing, anaesthesia, vascular access, and animal welfare.

Product overview

Ellegaard Göttingen Minipigs operates as a breeding and research services company offering a portfolio centered on Göttingen Minipigs for biomedical research. The core offering is the Göttingen Minipig itself—a barrier-bred research animal available in various ages and specifications. This is supplemented by Genetically Altered Göttingen Minipigs (notably the Humanized IgG 1/4 variant for antibody therapeutics testing), Biological Material for in vitro studies, and Research Services including in vivo study execution. The Göttingen Minipigs Academy provides complementary educational training. The company positions itself as enabling safer and more effective medicine development through preclinical research support.

Differentiator

Problem solved

Functional benefit

Brands

• Göttingen Minipigs Academy: Educational platform offering courses, webinars and training on Göttingen Minipigs in biomedical research
• Humanized IgG1/IgG4 Göttingen Minipigs
• Göttingen Micropigs

Products and services

• Göttingen Minipigs Barrier-bred Göttingen Minipigs supplied in all ages, weight groups, and both genders for biomedical research, including toxicology, safety assessment, PK, and regulatory studies. Targeted at pharmaceutical companies, biotech firms, CROs, and academic research institutions.
• Genetically Altered Göttingen Minipigs (Humanized IgG 1/4) Genetically modified Göttingen Minipigs carrying human immunoglobulin heavy chain (γ1/γ4) and κ light chain genes, providing tolerance to a broad range of human antibodies and a viable alternative to non-human primates for toxicology testing of therapeutic antibodies. Targeted at biotech and pharma developers of biologics and antibody therapeutics.
• Biological Material

Quantifiable outcome

• Humanized IgG Göttingen Minipigs tolerated clinically non-immunogenic IgG1κ-isotype monoclonal antibodies daratumumab and bevacizumab, enabling in vivo testing
• +2 more outcomes

Named customers10 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Six partnerships are on record, tiered core, major and moderate.

• Scantox GroupcoreStrategic or Co-development Partner · 1 February 2023Collaboration on Humanized Göttingen Minipigs research and commercialization. Joint round table meetings and scientific symposia. Scantox Group hosts registration for Humanized IgG Göttingen Minipigs events and facilitates collaboration between Ellegaard and researchers.
• CENSE (Center for Experimental Neuroscience), Aarhus UniversitycoreStrategic or Co-development PartnerDevelopment and publication of the Atlas of the Göttingen Minipigs brain - comprehensive histological sections paired with MRI scans for research purposes.
• EU Project NH Pig ConsortiummajorStrategic or Co-development PartnerEU-funded consortium project aimed at replacing non-human primates (NHPs) with Göttingen Minipigs in drug development. New initiative to advance regulatory acceptance and scientific validation of minipigs as alternative species.
• University of CopenhagenmoderateStrategic or Co-development PartnerCollaboration on multiple research projects including gut microbiome studies, inhalation therapy research, and anti-SARS-CoV-2 drug testing in Göttingen Minipigs.
• AZE ConsultingmoderateImplementation/ SI/ Consulting PartnerAdrian Zeltner from AZE Consulting serves as lecturer for Vascular Access and Anaesthesia & Analgesia courses in the Göttingen Minipigs Academy, providing specialized training expertise.
• Minipig Research ForumcoreStrategic or Co-development PartnerNon-profit organization facilitating knowledge sharing among minipig researchers. EGM facilitates practical organization and webpage. Joint annual forums for discussing minipig use in biomedical research.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• WuXi AppTec: Global preclinical CRO with extensive toxicology and safety assessment services across multiple species. Competes with EGM for outsourced preclinical toxicology budgets and is also a potential distribution/scale partner in Asia.
• The Jackson Laboratory: Major nonprofit research model provider, primarily in mice, with extensive background data, distribution, and scientific services. Comparable scientific data library and translational research infrastructure, though focused on rodent models.
• Inotiv: Research models and preclinical services provider (formed via Envigo integration). Offers research animal models and contract research services overlapping with EGM's customer base in toxicology.
• Charles River Laboratories: Large incumbent supplying research models (including NHPs and other species), preclinical CRO services, and biologics testing to global pharma. Competes with EGM in the broader preclinical research services and animal model market.

Others

• Labcorp Drug Development (Covance): Large preclinical CRO that is both a customer of EGM (uses Göttingen Minipigs for inhalation toxicology) and a competitor in preclinical contract research. Useful adjacency given the dual customer/competitor relationship.

Direct peers

• Janvier Labs: Independent breeder of laboratory animals (including minipigs) for academic and industry research. Direct comparable in purpose-bred research animal supply with similar European scientific customer base.
• Marshall BioResources: Global breeder and supplier of purpose-bred laboratory animals including Göttingen Minipigs, miniature swine, rabbits, and rodents for biomedical research. Direct competitor in the same minipig strain and adjacent research models.
• SNBL USA: Preclinical CRO specializing in NHP and other species toxicology studies for pharma/biotech. Competes in the upstream drug safety testing market where EGM's minipigs are positioned as an alternative.
• Taconic Biosciences: Supplier of genetically engineered and preconditioned research animal models for drug discovery. Comparable specialty model provider selling into the same pharma/biotech translational research customer base.
• Sinclair Bio Resources: Breeder of Sinclair miniature swine for biomedical and preclinical research applications. Closest direct peer in miniature swine research models serving similar toxicology customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/ellegaard-gottingen-minipigs

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles15 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ellegaard Göttingen Minipigs